Journal ID (nlm-ta): Antimicrob Agents Chemother
Journal ID (iso-abbrev): Antimicrob. Agents Chemother
Journal ID (hwp): aac
Journal ID (pmc): aac
Journal ID (publisher-id): AAC
Title:
Antimicrobial Agents and Chemotherapy
Publisher:
American Society for Microbiology
(1752 N St., N.W., Washington, DC
)
ISSN
(Print):
0066-4804
ISSN
(Electronic):
1098-6596
Publication date
(Electronic preprint):
2
January
2019
Publication date
(Electronic):
26
February
2019
Publication date Collection:
March
2019
Publication date PMC-release: 26
February
2019
Volume: 63
Issue: 3
Electronic Location Identifier: e02204-18
Affiliations
[a
]Institute for Tuberculosis Research, College of Pharmacy, University of Illinois at
Chicago, Chicago, Illinois, USA
[b
]Department of Medicinal Chemistry & Pharmacognosy, College of Pharmacy, University
of Illinois at Chicago, Chicago, Illinois, USA
[c
]Center for Biomolecular Sciences, College of Pharmacy, University of Illinois at Chicago,
Chicago, Illinois, USA
[d
]Center for Nutraceutical and Pharmaceutical Materials, Myongji University, Cheoin-gu,
Gyeonggi-do, Republic of Korea
[e
]Division of Bioscience and Bioinformatics, College of Natural Science, Myongji University,
Cheoin-gu, Gyeonggi-do, Republic of Korea
[f
]Department of Microbiology, Chungnam National University School of Medicine, Daejeon,
Republic of Korea
[g
]Infection Control Convergence Research Center, Chungnam National University School
of Medicine, Daejeon, Republic of Korea
[h
]Department of Laboratory Medicine, Pusan National University Yangsan Hospital, Yangsan,
Republic of Korea
[i
]International Tuberculosis Research Center, Changwon, Republic of Korea
Author notes
[*]
Present address: Jeffrey R. Anderson, AbbVie, Discovery-Oncology, North Chicago, Illinois,
USA; Wei Gao, Nature’s Sunshine Products, Inc., Lehi, Utah, USA.
Citation Choules MP, Wolf NM, Lee H, Anderson JR, Grzelak EM, Wang Y, Ma R, Gao W, McAlpine
JB, Jin Y-Y, Cheng J, Lee H, Suh J-W, Duc NM, Paik S, Choe JH, Jo E-K, Chang CL, Lee
JS, Jaki BU, Pauli GF, Franzblau SG, Cho S. 2019. Rufomycin targets ClpC1 proteolysis
in
Mycobacterium tuberculosis and
M. abscessus. Antimicrob Agents Chemother 63:e02204-18.
https://doi.org/10.1128/AAC.02204-18.
Article
Publisher ID:
02204-18
DOI: 10.1128/AAC.02204-18
PMC ID: 6395927
PubMed ID: 30602512
SO-VID: aec3679f-92ba-4fa0-bfd2-4f722fea40a5
Copyright © Copyright © 2019 Choules et al.
License:
This is an open-access article distributed under the terms of the
Creative Commons Attribution 4.0 International license.
Page count
supplementary-material: 1,
Figures: 9,
Tables: 5,
Equations: 1,
References: 56,
Pages: 17,
Words: 10838
Funded by: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), https://doi.org/10.13039/100000060;
Award ID: R21 AI093919-02
Award Recipient
:
Birgit U. Jaki
Funded by: Rural Development Administration (RDA), https://doi.org/10.13039/501100003627;
Award ID: PJ01319101
Award Recipient
:
Joo-Won Suh
Funded by: Rural Development Administration (RDA), https://doi.org/10.13039/501100003627;
Award ID: PJ01328403
Award Recipient
:
Sanghyun Cho
Funded by: Ministry of Science, ICT and Future Planning (MSIP), https://doi.org/10.13039/501100003621;
Award ID: 2017R1A5A2015385
Award Recipient
:
Eun-Kyeong Jo
Funded by: HHS | NIH | National Center for Complementary and Integrative Health (NCCIH), https://doi.org/10.13039/100008460;
Award ID: T32AT007533
Award Recipient
:
Guido F. Pauli